PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease

This publication has 51 references indexed in Scilit:

• Inflammatory bowel disease
  Alimentary Pharmacology & Therapeutics, 2003
• The Specific Type-4 Phosphodiesterase Inhibitor Mesopram Alleviates Experimental Colitis in Mice
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• Effect of Dexamethasone on the Metabonomics Profile Associated with Phosphodiesterase Inhibitor-Induced Vascular Lesions in Rats
  Toxicology and Applied Pharmacology, 2002
• Interferon-? sensitizes colonic epithelial cell lines to physiological and therapeutic inducers of colonocyte apoptosis
  Journal of Cellular Physiology, 2000
• Dextran Sulfate Sodium-Induced Colonic Histopathology, but not Altered Epithelial Ion Transport, Is Reduced by Inhibition of Phosphodiesterase Activity
  The American Journal of Pathology, 2000
• Enhanced production of monocyte chemotactic protein 3 in inflammatory bowel disease mucosa
  Gut, 1999
• Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine
  Alimentary Pharmacology & Therapeutics, 1998
• Curative effects of phosphodiesterase 4 inhibitors in dextran sulfate sodium-induced colitis in the rat
  Gastroenterology, 1998
• Review article: β₃‐adrenoceptor agonists—future anti‐inflammatory drugs for the gastrointestinal tract?
  Alimentary Pharmacology & Therapeutics, 1996
• The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-α production by human mononuclear cells
  International Journal of Immunopharmacology, 1993